Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Seglin Technology: A Major Source of Novel Small-Molecule Drugs

Second generation leads from iminosugars (SeglinsTM) show improved potency and selectivity over earlier examples and offer potential as novel small-molecule drugs across a wide range of therapeutic areas.

Richard Storer and Graeme Horne at Summit plc (September 2010)

Keywords: Second generation iminosugars SeglinsTM potency selectivity novel small-molecule drugs therapeutic

    View full article    |    Back to Biopharma section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |